Surgical Treatment of Marfan Syndrome With Subluxation Lens

Effect of Different Surgical Treatment of Marfan Syndrome With Subluxation Lens

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05578469

Enrollment

Registered

2022-10-13

Start date

2016-01-01

Completion date

2024-12-30

Last updated

2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lens Subluxation or Dislocation, Marfan Syndrome

Brief summary

To analyze the postoperative visual effects, and to compare the safety and efficacy of different surgical treatment with of Marfan Syndrome with subluxation lens.

Interventions

PROCEDUREsurgical treatment of Marfan Syndrome with subluxation lens

different surgical treatment of Marfan Syndrome with subluxation lens

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

8 Years to 55 Years

Healthy volunteers

Inclusion criteria

1. Patients diagnosed with MFS according to the revised Ghent etiology. 2. refractive errors difficult to correct. 3. pupillary block glaucoma caused by severe dislocation of the lens

Exclusion criteria

Keratoconus, late glaucoma, uveitis, history of traumatic lens dislocation, and preoperative retinal rupture with or without retinal detachment (RD)

Design outcomes

Primary

Measure	Time frame
Uncorrected distance visual acuity	1 month postoperatively
Corrected distance visual acuity	1 month postoperatively
intraocular pressure	1 month postoperatively
postoperative complication	Early and late stages

Secondary

Measure	Time frame
Postoperative astigmatism and astigmatism axial of cornea	1 month postoperatively
endothelial cell count	1 month postoperatively

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026